Results 81 to 90 of about 12,633 (172)

Slow Wave Activity During Nocturnal Sleep in Hypersomnolence Disorder

Journal of Sleep Research, Volume 35, Issue 5, October 2026.
ABSTRACT Slow waves during non‐rapid eye movement (NREM) sleep are associated with the restorative aspects of sleep. Previous research has suggested reduced normalized slow wave activity (SWA), particularly in the first cycle of NREM sleep, as a feature of hypersomnolence disorder (HD); however, the scarcity of existing research highlights the need for
Jesse D. Cook, Brady A. Riedner, Meredith E. Rumble, Michael R. Goldstein, Ana Maria Vascan, Kieulinh M. Tran, David T. Plante   +6 more
wiley   +1 more source

A Case of Sporadic Creutzfeldt-Jakob Disease Mimicking Variant Form

İstanbul Medical Journal, 2017
Creutzfeldt-Jakob Disease (CJD) is a rare neurodegenerative disease that causes a rapidly progressive dementia, and it can be classified as sporadic, heritable, and variant (acquired).
Osman Özgür Yalın, İrem Baş, Ufuk Emre, Orhan Yağız, Yüksel Erdal   +4 more
doaj   +1 more source

The Epidemiology of Creutzfeldt-Jakob Disease in Canada: A Review of Mortality Data

Emerging Infectious Diseases, 1997
Creutzfeldt-Jakob disease (CJD), and particularly its transmissibility through blood and blood products, has become a focus of concern in Canada. The recent identification of new variant CJD led to a review of the Canadian mortality database to identify ...
Elizabeth Stratton, Maura N. Ricketts, Paul R. Gully   +2 more
doaj   +1 more source

Correction: Comparative evaluation of clinical and cerebrospinal fluid biomarker characteristics in rapidly and non‑rapidly progressive Alzheimer’s disease

Alzheimer’s Research & Therapy, 2023
Janne Marieke Herden, Peter Hermann, Isabel Schmidt, Kathrin Dittmar, Sezgi Canaslan, Luise Weglage, Sabine Nuhn, Corinna Volpers, Astrid Schlung, Stefan Goebel, Fabian Kück, Anna Villar‑Piqué, Christian Schmidt, Dirk Wedekind, Inga Zerr   +14 more
doaj   +1 more source

Creutzfeldt-Jakob disease: A great masquerade in neurology, a rare case report from South India

Journal of the Scientific Society, 2015
Creutzfeldt-Jakob disease (CJD) is a rare, fatal neurodegenerative disease caused by an infectious protein called prion and is characterized by spongiform changes, neuronal loss, reactive astrocytic proliferation, and accumulation of pathologic cellular ...
Sivaprakash Varadan, Sudagar Singh, Deepak Rajkumar Vangipuram, Damodharan Jayachandran   +3 more
doaj   +1 more source

Canadian Creutzfeldt-Jakob disease incidence remained stable during the coronavirus disease (COVID-19) pandemic

Frontiers in Neurology
IntroductionHealthcare disruptions imposed by the coronavirus disease (COVID-19) pandemic and possible biological links between SARS-CoV-2 and prion misfolding might influence the prevalence or characteristics of Creutzfeldt-Jakob Disease (CJD).
Jessy A. Slota, Dobrila Todoric, Vanessa Bergeron, Kristen Avery, Clark Phillipson, Dominic M. S. Kielich, Jennifer Myskiw, Lise Lamoureux, Kathy Frost, Sharon L. R. Simon, Ben A. Bailey-Elkin, Stephanie A. Booth, Stephanie A. Booth   +12 more
doaj   +1 more source

CJD: Update for Dental Staff

, 2006
It is almost a decade since the recognition of the emergence of a new infectious disease termed variant Creutzfeldt-Jakob disease (vCJD) caused by prions (PrPTSE), abnormal variants of a normal human cell surface protein (PrP). This disease has a number
Crispian Scully, J Bagg, Andrew J Smith
core   +1 more source

The Importance of Rapid Consideration of Creutzfeldt- Jakob Disease in the Differential Diagnosis of Progressive Neurodegenerative Disease: A Case Report

International Journal of Medical Students, 2016
Background: Creutzfeldt-Jakob disease (CJD) is a prion disease characterized by misfolded proteins that lead to neurodegeneration and inevitable death. Classic sporadic CJD presents primarily with cognitive symptoms and ataxia without visual impairment ...
Arthur Joseph, Jacob Core, Daniel Solano, Marquand Patton, Shaun Smart   +4 more
doaj   +1 more source

Changes in 14-3-3 protein and PrP levels in CSF from six CJD patients overtime.

, 2013
PrP and 14-3-3 protein levels were analyzed in CSF samples obtained by lumbar puncture of 6 CJD patients (CJD-1 to CJD-6) at different time points during disease.
Nancy Hernández (324681), José Manuel Matamala (324680), Claudio Hetz (159190), Mauricio Torres (234054), Ute Woehlbier (184777), Luis Cartier (324679)   +5 more
core   +1 more source

Decontamination of prions, prion-associated amyloid and inefectivity from surgical stainless steel - implications for the risk of iatrogenic transmission of CJD

, 2009
The physicochemical nature of the infectious agent in prion diseases creates asignificant challenge for decontamination services. It has been shown to be both resistant tostandard methods of decontamination, used to inactivate viruses and bacteria, and ...
Howlin, Robert
core   +1 more source